{"resourceType":"ValueSet","id":"c22ca79c-6d99-11ec-a98d-00163efae4c9","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><ul><li>Include these codes as defined in <a href=\"http://loinc.org\"><code>http://loinc.org</code></a> version <code>2.7</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/2011-5.html\">2011-5</a></td><td>Cancer Ag 242 [Presence] in Serum or Plasma</td></tr></table></li></ul></div>"},"url":"http://projectronin.com/fhir/us/ronin/ValueSet/c22ca79c-6d99-11ec-a98d-00163efae4c9","version":"0.9.5","name":"CA242","title":"CA242","status":"active","experimental":false,"date":"2022-03-14T18:28:42+00:00","publisher":"Project Ronin Inc.","contact":[{"name":"Project Ronin Inc.","telecom":[{"system":"url","value":"https://www.projectronin.com"},{"system":"email","value":"contact@projectronin.com"}]}],"description":"LOINC codes indicating the measurement of CA242 MVP for ED risk model release","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US","display":"United States of America"}]}],"immutable":false,"compose":{"include":[{"system":"http://loinc.org","version":"2.7","concept":[{"code":"2011-5","display":"Cancer Ag 242 [Presence] in Serum or Plasma"}]}]}}